Portfolio company
Nplex Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Range Biotechnologies
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
Alamar Biosciences
This company develops high-sensitivity proteomics platforms and protein biomarker detection assays for life sciences researchers and clinicians in drug development and disease research.
NAUT
This company develops a proteomic analysis platform to measure proteins for researchers, drug developers and diagnostic organisations.
Palamedrix
This company develops DNA nanotechnology and biosensor platforms for multi-omic detection and proteomic analysis for biopharmaceutical and academic research markets.
Nomic Bio
Nomic Bio develops high-throughput protein profiling platforms and assays for pharmaceutical, biotechnology and academic researchers to accelerate drug and biomarker discovery.
Glyphic Biotechnologies
This company develops a single-molecule protein sequencing platform for researchers and institutions focused on biological research and drug discovery.
Protillion Biosciences
This company develops a high-throughput protein engineering platform for pharmaceutical partners to accelerate the discovery and optimisation of therapeutic antibodies and binder drugs.
